According to Precision Business Insights, the Active Pharmaceutical Ingredients Market research report provides industry size and growth.
Active Pharmaceutical Ingredients Market size was valued at USD 251.3 billion in 2022 and is expected to grow at a CAGR of 6.1% from 2023-2029. Active pharmaceutical ingredient is biologically active and is a part of the drug which produces pharmacological effect. Some drugs which are used in a combination therapy have multiple active pharmaceutical ingredients (API) to treat more than one symptoms. Active pharmaceutical ingredients used for making the wide range of drugs that used to treat chronic diseases such as cancer, metabolic disorders, cardiovascular disorders, and neurological disorders, and others.Active pharmaceutical ingredient is biologically active and is a part of the drug which produces pharmacological effect. Some drugs which are used in a combination therapy have multiple active pharmaceutical ingredients (API) to treat more than one symptoms. Active pharmaceutical ingredients used for making the wide range of drugs that used to treat chronic diseases such as cancer, metabolic disorders, cardiovascular disorders, and neurological disorders, and others.
The major factors driving the API market growth include increase in the incidence of chronic diseases, and penetration of healthcare systems in underdeveloped countries and increased the consumption of drugs are expected to fuel the growth of active pharmaceutical ingredient (API) market. Furthermore, a surge in healthcare spending, development of healthcare infrastructure around the world enables boost the growth of active pharmaceutical ingredients market. However, unfavorable drug pricing policies in some countries and stringent regulatory requirements are hampering the active pharmaceutical ingredient market.
The global API market have been divided into following categories-
Type of synthesis
Application area
Geographical regions,
Request Sample: https://www.precisionbusinessinsights.com/request-sample/?product_id=109462
North America accounts major pie in API market. In addition, a rise in biotechnological advances led to rising demand for the active pharmaceutical ingredients in North America region. Asia-Pacific is expected to record the fastest CAGR owing to many manufacturers and favorable government policies in the region.
Europe API market is expected to grow at a significant rate owing to manufacturers prioritizing high-quality standards, advanced manufacturing installations, and high purity of intermediates.
Some of the key players in API market are Pfizer, Inc. (U.S.), Sanofi (France), Lonza Group (Switzerland), Boehringer Ingelheim (Germany), Novartis AG (Switzerland), GlaxoSmithKline plc (U.K.), Bristol-Myers Squibb (U.S.), Zhejiang Hisun Pharmaceutical Co., Ltd. (China), Aenova Group GmbH (Germany), Catalent, Inc. (U.S.), Teva Pharmaceutical Industries Ltd., (Israel) Aurobindo Pharma Limited (India), Eli Lilly and Company (U.S.), AbbVie Inc. (U.S.)., and Merck & Co., Inc. (U.S.) to name a few.Active Pharmaceutical Ingredient Market is witnessing robust growth rate due to highly fragments of various players. Market players are banking on mergers and acquisitions to expand their manufacturing capabilities, geographical expansions and to increase the market share.
Key Questions Answered
Reasons to buy active pharmaceutical ingredients market Report:
About Precision Business Insights:
Precision Business Insights is one of the leading market research and business consulting firm, which follow a holistic approach to solve needs of the clients. We adopt and implement proven research methodologies to achieve better results. We help our clients by providing actionable insights and strategies to make better decisions. We provide consulting, syndicated and customised market research services based on our client needs.
Contact Us:
Precision Business Insights
Kemp House,152-160 City Road,
London EC1V 2NX
Email: [email protected]
Toll Free (US):+1-866-598-1553
Website @www.precisionbusinessinsights.com